Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1049 | 1046 | 1006 | 963 | 1192 | 1790 |
Fund Return | 4.91% | 4.61% | 0.61% | -1.25% | 3.58% | 5.99% |
Place in category | 452 | 353 | 600 | 537 | 427 | 120 |
% in Category | 72 | 63 | 99 | 96 | 83 | 49 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Canadian Dividend Fund Series I | 20.78B | 3.24 | 8.68 | 7.64 | ||
RBC Canadian Div Fund Series D CAD | 20.78B | 3.06 | 8.09 | 7.03 | ||
RBC Canadian Div Fund Series F CAD | 20.78B | 3.15 | 8.40 | 7.33 | ||
RBC Sel Gr Port Sr F CAD | 16.29B | 4.98 | 4.18 | 7.38 | ||
RBC Sel Gr Port Sr T5 | 16.29B | 4.63 | 3.14 | 6.29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mawer International Equity Fund Cla | 7.48B | 6.04 | 1.84 | 6.78 | ||
DFA International Core Equity Class | 3.05B | 6.00 | 4.49 | 6.37 | ||
RBC International Equity Sr F CAD | 2.4B | 7.39 | 4.63 | 7.67 | ||
RBC International Equity Fund D CAD | 2.4B | 7.29 | 4.34 | 7.39 | ||
Sun Life MFS Intl Value A T5 | 2.17B | 8.18 | 2.01 | 7.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.33 | 927.3 | +1.13% | |
Safran | FR0000073272 | 5.77 | 214.10 | +0.14% | |
Taiwan Semiconductor | US8740391003 | 5.42 | 151.06 | -1.24% | |
Anheuser Busch Inbev | BE0974293251 | 5.18 | 57.62 | 0.00% | |
InterContinental | GB00BHJYC057 | 4.92 | 7,900.0 | +1.88% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review